louisiana glp-1 intestinal paralysis legal team The RA Timeline: How Serious Side Effects Led to Multidistrict Litigation Wegovy Lawsuit | Louisiana Lawyer

Description

Stopping GLP-1 therapy after reaching your weight loss goal requires careful planning

FDA approves Jardiance (empagliflozin) tablets to reduce the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease

Metabolic alterations have been studied in the myocardium of heart failure (HF) patients

By including all English-language studies on muscle mass loss during GLP-1RA therapy in T2D and obesity from major scientific databases and clinical trial registries, this narrative review synthesizes the current knowledge on the epidemiology and mechanisms of muscle loss in diabetes and obesity, with a focus on the impact of GLP-1RAs therapy